Mitera Biosciences
PrivateLast Round
Seed Round
May 6, 2026
Total Funding Raised
$1.75M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mitera Biosciences is a biotechnology company that develops investigational therapeutics for the treatment of autoimmune and alloimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mitera Biosciences Comparables
Compare Mitera Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GentiBio | 81% | |
| RegCell, Inc. | 79% | |
| Egle Therapeutics | 78% |
Mitera Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 6, 2026 | ||||
| Seed | Dec 30, 2025 |
Mitera Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cedars Sinai Health Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Monthly visitors increased 177% MoM, reaching 1K.
- May 15, 2026
Monthly visitors grew 631% MoM, from 51 to 373.
Mitera Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mitera Biosciences's valuation, stock price, and market status.
Is Mitera Biosciences a public or private company?
Mitera Biosciences is a private company.
What is the current stock price of Mitera Biosciences?
Mitera Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Mitera Biosciences worth (valuation)?
Valuation information for Mitera Biosciences is not publicly available.
Can I buy Mitera Biosciences stock?
Mitera Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mitera Biosciences's last funding round?
Mitera Biosciences's most recent funding round was Seed Round on May 6, 2026.
Who are the main investors in Mitera Biosciences?
Key investors in Mitera Biosciences include Cedars Sinai Health Ventures.
Will Mitera Biosciences IPO soon?
No public IPO plans have been announced for Mitera Biosciences.
How can I track Mitera Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mitera Biosciences's secondary market activity and sign up for updates.